Structure

(S)-3-Isopropylmorpholine

CAS
77897-21-3
Catalog Number
ACM77897213
Category
Other Products
Molecular Formula
C7H15NO

If you have any other questions or need other size, please get a quote.

  • Product Description
  • Case Study
  • Custom Reviews
  • Custom Q&A
  • Synthetic Use
  • Related Resources

Upstream Synthesis Route 1

  • 127958-60-5
  • 77897-21-3

Reference: [1]Current Patent Assignee: BRISTOL-MYERS SQUIBB CO - US2016/289171, 2016, A1
Location in patent: Paragraph 0678
[2]Current Patent Assignee: CURIA INC - US2008/255114, 2008, A1
Location in patent: Page/Page column 17
[3]Current Patent Assignee: Novartis (w/o Sandoz); NOVARTIS AG - US2012/28969, 2012, A1
Location in patent: Page/Page column 80

Upstream Synthesis Route 2

  • 2026-48-4
  • 77897-21-3

Reference: [1]Current Patent Assignee: Novartis (w/o Sandoz); NOVARTIS AG - US2012/28969, 2012, A1
[2]Current Patent Assignee: BRISTOL-MYERS SQUIBB CO - US2016/289171, 2016, A1

Downstream Synthesis Route 1

  • 77897-21-3
  • 1007112-35-7
  • 1014713-51-9

Reference: [1]Location in patent: scheme or table
Yang, Zhicai; Fairfax, David J.; Maeng, Jun-Ho; Masih, Liaqat; Usyatinsky, Alexander; Hassler, Carla; Isaacson, Soshanna; Fitzpatrick, Kevin; Deorazio, Russell J.; Chen, Jianqing; Harding, James P.; Isherwood, Matthew; Dobritsa, Svetlana; Christensen, Kevin L.; Wierschke, Jonathan D.; Bliss, Brian I.; Peterson, Lisa H.; Beer, Cathy M.; Cioffi, Christopher; Lynch, Michael; Rennells, W. Martin; Richards, Justin J.; Rust, Timothy; Khmelnitsky, Yuri L.; Cohen, Marlene L.; Manning, David D.
[Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 22, p. 6538 - 6541]

* For details of the synthesis route, please refer to the original source to ensure accuracy.

Please kindly note that our products are for research use only.

Alfa Chemistry

For product inquiries, please use our online system or send an email to .

Alfa Chemistry
Shopping basket
Loading...
Loading...
Download PDF documentDownload
* I hereby give my consent that I may receive marketing e-mails with information on existing and new services from this company. I know that I can opt-out from receiving such e-mails at any time or by using the link which will be provided in each marketing e-mail.